Senate Bill 1008
115th Congress(2017-2018)
Therapeutic Hemp Medical Access Act of 2017
Introduced
Introduced in Senate on May 2, 2017
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1008
Congress
115
Policy Area
Crime and Law Enforcement
Crime and Law Enforcement
Primary focus of measure is criminal offenses, investigation and prosecution, procedure and sentencing; corrections and imprisonment; juvenile crime; law enforcement administration. Measures concerning terrorism may fall under Emergency Management or International Affairs policy areas.
Cory Gardner
grade
Colorado
Georgia
Minnesota
Missouri
Oregon
Oregon
South Carolina
Tennessee
Utah
Utah
Virginia
Wisconsin
Wisconsin
No Senate votes have been held for this bill.
Summary
Therapeutic Hemp Medical Access Act of 2017
This bill amends the Controlled Substances Act (CSA):
- to add definitions for the terms "cannabidiol," "cannabidiol-rich plants," and "tetrahydrocannabinol concentration";
- to exclude cannabidiol and cannabidiol-rich plants from the definition of marijuana; and
- to remove cannabidiol and cannabidiol-rich plants from coverage under the CSA.
It also specifies that no provision of this bill prohibits or restricts the use, production, or distribution of marijuana in a state in which such activities are legal under state law.
May 2, 2017
05/02/2017
Read twice and referred to the Committee on the Judiciary.
05/02/2017
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:36:31 PM